Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-19

FDA Approved: SUMATRIPTAN — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

This FDA entry documents the original approval of sumatriptan by Baxter Healthcare Corporation for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)